Key points are not available for this paper at this time.
As an automated and quantitative measure of global endoscopic disease severity, the CDS offers artificial intelligence enhancement of traditional MES capability to better evaluate UC in clinical trials and potentially practice.
Stidham et al. (Wed,) studied this question.